导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 14.06% | 266/1050 |
| 近一周 | 0.37% | 232/1104 |
| 近一月 | -4.26% | 692/1103 |
| 近一季 | -11.05% | 753/1092 |
| 近半年 | 8.75% | 272/1070 |
| 近一年 | 17.42% | 281/1018 |
| 近两年 | 101.87% | 196/926 |
| 近三年 | 57.31% | 226/834 |
| 成立以来 | 276.70% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.75% 542/1070 |
42.71% 256/1101 |
- - |
- - |
| 2025 | 33.27% 422/1065 |
1.63% 672/1014 |
0.25% 663/1038 |
33.85% 299/1050 |
-2.28% 574/1065 |
| 2024 | 8.94% 317/1011 |
-4.03% 536/960 |
-5.71% 673/983 |
16.02% 176/991 |
3.76% 167/1011 |
| 2023 | -12.26% 407/952 |
7.81% 177/880 |
-3.28% 400/895 |
-11.52% 654/915 |
-4.90% 488/952 |
| 2022 | -27.21% 558/867 |
-19.14% 472/773 |
7.54% 371/806 |
-16.68% 663/845 |
0.46% 427/867 |
| 2021 | 22.73% 136/740 |
-5.11% 344/580 |
22.85% 121/659 |
- 216/704 |
5.28% 211/740 |
| 2020 | 43.41% 278/554 |
0.68% 149/419 |
23.83% 213/466 |
4.76% 367/517 |
9.81% 363/554 |
| 2019 | 71.11% 36/410 |
38.34% 84/1149 |
-4.65% 684/1231 |
15.03% 37/390 |
12.76% 98/410 |
| 2018 | -29.14% 203/349 |
- - |
- - |
- - |
-12.71% 692/1080 |
| 2017 | 8.91% 140/285 |
- - |
- - |
- - |
- - |
| 2016 | -17.50% 103/205 |
- - |
- - |
- - |
- - |
| 2015 | 50.33% 22/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 华安大国新经济股票A VS. 东吴新产业精选股票A(580008) |